1.
Recombinant adeno-associated virus (AAV) vectors predominantly remain episomal and integrate randomly at low frequency, raising safety concerns for gene therapy. We devel [...]
2007 | Thesis |
2.
Adeno-associated virus (AAV) is widely used in gene therapy but has limited integration, reducing long-term transgene expression. We engineered an AAV-rDNA vector to enha [...]
2012 | Dissertation |